Mammography demonstrates another, 1-cm, low density, well-defined mass in the outer portion of the left breast (arrow). US image (b) shows round, homogenously hypoechoic masses in the inner and outer portion of the left breast. Core needle biopsy revealed that large mass was fibroadenoma (not shown) and the small one was mucinous carcinoma. Histologic slide (c) demonstrates that clusters of carcinoma cells are present in the mucin polls (hematoxylin-eosin stain, original magnification, ×100). 
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Papillary carcinoma
Papillary carcinoma accounts for 1%-2% of breast carcinomas (6) . It generally occurs in women over 60 years old. Patients with papillary carcinoma often present a palpable central mass or bloody nipple discharge (6, 7) . It is characterized by slow growth and better prognosis compared to ductal carcinomas not otherwise specified. The frequency of axillary nodal metastases is low (6, 7) . The mammographic appearance is a solitary round or lobulated, relatively circumscribed mass or clusters of masses (6, 7) , which may be associated with microcalcifications. The tumor can mimic a benign ductal papilloma at mammography (3). On US, papillary carcinoma often manifests as a single or multiple circumscribed solid mass or a complex cystic mass ( Fig. 3) (3, 7) . On histopathologic examination, the tumor can have in situ (intracystic or intraductal) or invasive components. In the in situ component, the neoplastic epithelial cells are usually characteristic of low-grade ductal carcinoma in situ. The absence of a uniform layer of myoepithelial layer distinguishes papillary carcinomas from benign papillary lesions (6).
Medullary carcinoma
Medullary carcinomas account for fewer than 2% of breast carcinomas (3). It occurs more frequently in women aged 35 years or younger (8, 9) . It is a rapidly growing tumor and manifests as a palpable mass. The mammographic appearance is usually an uncalcified mass with ill-defined or circumscribed borders (8) . Mammography cannot help distinguish true from atypical medullary carcinomas of the breast. On US, the tumor manifests as a homogeneous or inhomogeneous hypoechoic mass with a well-defined margin ( Fig.  4) (3, 9) . Histopathologic examination reveals a well-circumscribed carcinoma composed of poorly differentiated cells with scant stroma and prominent lymphoid infiltration (8) . The histological appearance of medullary carcinoma mimics atypical medullary carcinoma and IDC not otherwise specified (3, 8) . However, the prognosis for this type of carcinoma is good.
Metaplastic carcinoma
Metaplastic carcinoma is a heterogeneous carcinoma with mixed epithelial and mesenchymal differentiation. Metaplastic changes include squamous cell, spindle cell, and heterologous mesenchymal growth (10, 11) . It accounts for fewer than 5% of breast carcinomas (10, 11) . Clinically, the tumor manifests as a rapidly growing, palpable mass in women who are more than 50 years old (11) . Axillary lymph node metastasis is infrequent (10) . The mammographic appearance is a round, lobular, oval lesion with a predominantly circumscribed, high density mass (Fig.  5) (10, 11) . On US, metaplastic carcinoma may have complex echogenicity with solid and cystic components and may be microlobulated (10) .
Metastatic lesions
Breast metastases account for 0.5%-2% of breast carcinomas (12) . The lesions tend to be superficially located in the upper outer quadrant. They are much more likely to be multiple or bilateral compared to primary cancers. The mammographic appearance is usually a round mass with circumscribed b a or ill-defined margins. Axillary adenopathy is usually present (2, 12). On US, circumscribed, hypoechoic lesions are the usual feature (12) . The most common extramammary cancers that metastasize to the breast are lymphoma, melanoma, soft tissue sarcoma, and lung, ovarian, and renal cell carcinomas (2, 12).
Non-Hodgkin lymphoma
Breast lymphoma is a rare disease representing only 0.1%-0.5% of all breast cancers (12, 13) . Secondary involment is more common and is almost always of non-Hodgkin's type (2, 12) . The most common mammographic manifestation of non-Hodgkin's lymphoma, whether primary or secondary, is one or more uncalcified masses with circumscribed or relatively circumscribed margins (Fig. 6) (13) .
Diffuse increased parenchymal density in combination with skin thickening can be seen (13) . Bilateral axillary adenopathy is usually present (2, 12, 13) . The US appearance is a hypoechoic mass with circumscribed margins. At histopathologic examination, the most common type is a diffuse large cell (histiocytic) lymphoma. Lymph node architecture is needed for a definitive diagnosis (2) .
Plasmacytoma
Breast plasmacytoma is very rare. It may present as a solitary finding or in association with disseminated multiple myeloma (14, 15) . More than half of the lesions are unilateral, with the majority of the cases occurring in the setting of multiple myeloma (14, 15) . The mean age at presentation of breast plasmacytomas is 53 years. Tumors range in size from 1 to 7.5 cm (15) . The mammographic apperance is single or multiple well-defined masses without spiculations and microcalcifications. On US, the masses may be either welldefined or ill-defined. They are round and hypoechoic with posterior shadowing or enhancement (14, 15) . One patient with bilateral plasmacytoma is reported in this study. Mammographic examination demonstrated some masses with partial, lucent, halo signs (Fig.  7) . The mammography findings were similar to the non-specific findings documented in previous studies (15) . However, we observed well-defined hypoechoic masses containing central and peripheral hyperechoic rims on US (Fig. 7) . The ultrasonographic appearance of breast plasmacytoma in this study has not been previously reported. Histopathologic analysis of breast 
Conclusion
There is a number of unusual malignant lesions with variable appearances on mammography and/or US. Tubular, mucinous, papillary, and medullary carcinomas have better prognosis compared to IDC not otherwise specified. Except for medullary carcinoma, they are slow growing tumors, and except for tubular carcinoma, tumors appear as relatively well-defined masses on mammograms. Metastatic lesions of the breast tend to be superficially located in the upper outer quadrant. Axillary adenopathy is often present. Plasmacytoma usually occurs in the setting of multiple myeloma. The lesions may have a partial halo on mammograms, and peripheral and central hyperechoic rims on US. In conclusion, radiologists may be in a better position regarding sound and accurate diagnoses of malignant breast lesions when familiarized with their radiologic findings and specific clinical and imaging clues. 
